Published in Mol Cell Proteomics on July 14, 2014
Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling. Anal Chem (2015) 0.87
Recent findings and technological advances in phosphoproteomics for cells and tissues. Expert Rev Proteomics (2015) 0.81
Identifying Kinase Substrates via a Heavy ATP Kinase Assay and Quantitative Mass Spectrometry. Sci Rep (2016) 0.75
Estimating the Efficiency of Phosphopeptide Identification by Tandem Mass Spectrometry. J Am Soc Mass Spectrom (2017) 0.75
Protein networks and activation of lymphocytes. Curr Opin Immunol (2015) 0.75
The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease. Front Mol Neurosci (2017) 0.75
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 20.92
Oncogenic kinase signalling. Nature (2001) 16.30
Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res (2003) 15.74
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2012) 13.14
Signaling--2000 and beyond. Cell (2000) 11.78
A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A (2008) 10.07
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell (1991) 9.54
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell (1995) 9.27
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal (2010) 8.61
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res (2011) 7.84
Protein kinases--the major drug targets of the twenty-first century? Nat Rev Drug Discov (2002) 7.38
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta (2006) 7.33
An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol (2005) 5.93
The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors (2006) 5.58
A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol (2000) 5.46
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev (2011) 5.02
Mitogen-activated protein kinases in apoptosis regulation. Oncogene (2004) 4.76
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc Natl Acad Sci U S A (1997) 3.59
Universal and confident phosphorylation site localization using phosphoRS. J Proteome Res (2011) 2.93
A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature (1998) 2.89
PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res (2010) 2.61
Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci U S A (2008) 2.53
Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell (2009) 2.50
The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol (2005) 2.45
A semisynthetic epitope for kinase substrates. Nat Methods (2007) 2.40
Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal (2011) 2.33
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol (2001) 2.14
Mass spectrometry-based proteomics and network biology. Annu Rev Biochem (2012) 2.02
Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics (2009) 1.75
Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat Struct Mol Biol (2009) 1.64
In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol Cell Proteomics (2010) 1.62
Identification of CDK2 substrates in human cell lysates. Genome Biol (2008) 1.52
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood (2003) 1.48
CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene (2000) 1.47
Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res (1999) 1.39
The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie (2002) 1.39
Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism. Biochemistry (1998) 1.39
Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates. Proc Natl Acad Sci U S A (2012) 1.30
A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes. J Biol Chem (2001) 1.29
Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal (2011) 1.27
Neurotransmitters drive combinatorial multistate postsynaptic density networks. Sci Signal (2009) 1.24
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification. Nat Biotechnol (2009) 1.21
Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS One (2010) 1.17
Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol Cell Biol (2008) 1.09
An endosomally localized isoform of Eps15 interacts with Hrs to mediate degradation of epidermal growth factor receptor. J Cell Biol (2008) 1.08
A systematic MS-based approach for identifying in vitro substrates of PKA and PKG in rat uteri. J Proteome Res (2007) 1.07
Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J Proteome Res (2008) 1.06
Activated raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network. J Biol Chem (1998) 1.05
Mass spectrometry technologies for proteomics. Brief Funct Genomic Proteomic (2006) 1.00
Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol (2013) 0.99
Quantitative analysis of protein phosphorylation on a system-wide scale by mass spectrometry-based proteomics. Methods Enzymol (2010) 0.96
QIKS--Quantitative identification of kinase substrates. Proteomics (2010) 0.91
A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts. Skelet Muscle (2012) 0.88
PhosphoSiteAnalyzer: a bioinformatic platform for deciphering phospho proteomes using kinase predictions retrieved from NetworKIN. J Proteome Res (2012) 0.87
Universal quantitative kinase assay based on diagonal SCX chromatography and stable isotope dimethyl labeling provides high-definition kinase consensus motifs for PKA and human Mps1. J Proteome Res (2013) 0.86
Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor. Cell Signal (2001) 0.83
Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics. Mol Cell Proteomics (2013) 0.82
Inferring the Sign of Kinase-Substrate Interactions by Combining Quantitative Phosphoproteomics with a Literature-Based Mammalian Kinome Network. Proc IEEE Int Symp Bioinformatics Bioeng (2010) 0.81
A universal and multiplex kinase assay using γ-[(18)O(4)]-ATP. Chem Commun (Camb) (2013) 0.79